Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise

Originally posted on Bayer.com

Companies to continue crop protection development programs

Bayer and Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced the companies will continue the development of two crop protection programs. Farmers across the world are facing an increase in weed, insect and fungal resistance to current products on the market, and new mechanisms of action are needed to bolster integrated pest management systems. Based on previous and future successes, Bayer will advance the resulting compounds to field trials and further development.

Farmers across the world are facing an increase in weed, insect and fungal resistance to current products on the market, and new mechanisms of action are needed to bolster integrated pest management systems. (Photo cred via Bayer)

“Crop protection research is enhanced by data science, which can transform established methods into an integrated system focused on accelerated hypothesis-driven discovery,” said Axel Trautwein, Head of Small Molecules, Crop Science Division of Bayer. “We’re encouraged by what we have seen in the early stages of discovery and look forward to what this extended collaboration will bring.”

“The development of chemical compounds for agriculture is as challenging as it is for drug development,” said Dr. Abraham Heifets, CEO of Atomwise. “Most of the exciting targets have stymied previous development efforts. We’ve been able to deliver because of our unique technological breakthroughs, which let us screen billions of new chemical scaffolds against proteins that lack structural information or already-known drug series. We have shown repeatedly that our technology is effective using homology models and predicting binding to proteins across species, which is critical to selectivity and broad-spectrum activity. Bayer has been a great partner and we are excited that the compounds we helped to discover are moving forward,” he added.

Under the terms of the agreement, Atomwise will receive upfront payments for the research activities, as well as developmental milestones and royalty payments when products are commercialized.

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.

Bayer

Latest News

Discovery, Inc. Joins on Addressability Initiative with Distribution Partners Charter, Comcast and Cox to Enhance Addressable Capabilities Across Entire U.S. Portfolio of 18 Networks

Originally posted on Cox.com Advanced Advertising Technology Will Allow for Discovery Advertisers to Maximize Impact by Reaching Desired Consumers Discovery, Inc., the global leader in real-life entertainment, today announced it will join the On Address ability initiative, along with other major media organizations and distribution partners Charter’s Spectrum Reach, Comcast…

7 Podcasts to Add to Your Playlist That Talk Diversity

Podcasts, a growing source of information, have shown up as platforms that many diverse voices are using to connect, empower, inform, and advocate for change. There are more than 850,000 active podcasts and more than 30 million podcast episodes, based on studies from Nielsen and Edison. According to research, 70%…

EY Announces That it has Been Named as a Top Enterprise Blockchain Service Provider in Annual HFS Research Report

Originally published on EY.com Bold public blockchain market vision regarded as key differentiator EY ranked first among the Big Four, third overall EY today announces it has been ranked third in HFS Research’s annual Top 10 Enterprise Blockchain Services Report, based on the organization’s bold public blockchain market vision and software…

5 Ways to Show You Are a High-Potential Employee

Advancing your career and finding the right employer and position fit doesn’t have to be complicated. There are things you can do each day to move toward your dream job. The following article, part of the 5 Ways series, will show you a few different tactics to use to show your employer that you are a high-potential employee.